INIS
carcinomas
100%
patients
90%
tumors
83%
cancer
68%
humans
63%
genes
46%
metastases
29%
dna
25%
tissues
24%
lungs
24%
lung cells
23%
detection
21%
diseases
20%
mutations
19%
values
19%
risks
18%
comparative evaluations
17%
in-situ hybridization
15%
data
15%
biological markers
15%
fluorescence
13%
neoplasms
12%
chromosomes
12%
assessments
12%
proteins
11%
amplification
11%
classification
11%
instability
10%
paraffin
10%
reviews
10%
Keyphrases
High-risk Human Papillomavirus (HR-HPV)
43%
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
27%
Tumor
25%
Large Cell Neuroendocrine Carcinoma (LCNEC)
23%
Non-small Cell Lung Cancer (NSCLC)
22%
Pulmonary Carcinoid
21%
Immunohistochemistry
20%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
16%
Carcinoid
13%
HPV16
12%
Thoracic Oncology
12%
Overall Survival
11%
Fluorescence in Situ Hybridization
11%
Chromosomal Instability
10%
Merkel Cell Carcinoma
10%
Pathologist
9%
Programmed Death-ligand 1 (PD-L1)
9%
Adenocarcinoma
9%
Netherlands
9%
Multiplex Ligation-dependent Probe Amplification
9%
Formalin-fixed Paraffin-embedded Tissue
8%
Merkel Cell Polyomavirus (MCPyV)
8%
Molecular Subtypes
7%
Pulmonary Neuroendocrine Tumor
7%
Quantitative PCR
7%
Gene Expression
6%
Poor Prognosis
6%
Viral Load
6%
Atypical Carcinoid
6%
Next-generation Sequencing
6%
Medicine and Dentistry
Neoplasm
40%
Wart Virus
37%
Carcinoid
26%
Large Cell Neuroendocrine Carcinoma
23%
Neuroendocrine Tumor
19%
Non Small Cell Lung Cancer
17%
Immunohistochemistry
16%
Head and Neck Squamous Cell Carcinoma
14%
Overall Survival
13%
Oropharynx Carcinoma
13%
Lung
13%
Diagnosis
11%
Oropharynx Squamous Cell Carcinoma
10%
Metastatic Carcinoma
10%
Prevalence
9%
Pathologist
9%
Malignant Neoplasm
9%
Disease
9%
Epidermal Growth Factor Receptor
9%
Biological Marker
9%
Thoracic Oncology
9%
Non-Small Cell Lung Cancer
8%
Small Cell Lung Cancer
7%
Chromosomal Instability
6%
Adenocarcinoma
6%
Bone Metastasis
6%
Nesidioblastosis
6%
Mouth Squamous Cell Carcinoma
6%
Gene Mutation
6%
Programmed Death-Ligand 1
6%
